Zobrazeno 1 - 10
of 12
pro vyhledávání: '"James Nagaraj"'
Autor:
Pepijn van Houten, James Nagarajah, Janneke E W Walraven, Martin Jaeger, Adriana C H van Engen-van Grunsven, Johannes W Smit, Romana T Netea-Maier
Publikováno v:
European Thyroid Journal, Vol 13, Iss 4, Pp 1-9 (2024)
Objective: Patients with non-medullary thyroid carcinoma (NMTC) that are refractory to radioactive iodine (RAI) have a poor prognosis. Strategies for restoring the ability to take up iodine, so-called redifferentiation, are promising but not suitable
Externí odkaz:
https://doaj.org/article/8b42edffa11040c7b13500980dea3948
Autor:
Michiel Sedelaar, Jochem R.N. van der Voort van Zyp, Jeroen Kneppers, Sjoerd O. Klaver, Jeroen van Moorselaar, Niven Mehra, Stijn W.T.P.J. Heijmink, Herman Stoevelaar, Shafak S Aluwini, Wouter V. Vogel, Martijn P. Lolkema, Tom van der Hulle, James Nagaraj, Tom W. J. Scheenen, Guido Jenster, Hans M. Westgeest, Jules Lavalaye, Ivo G. Schoots, Eva E. Schaake, Inge M. van Oort, Daniela E. Oprea-Lager, Gisele H. J. M. Leyten, Irma M. Oving, Pim J. van Leeuwen, Luc M.F. Moonen, Theo M. de Reijke, Derya Yakar, Igle-Jan de Jong, Martijn B. Busstra, Kim de Vries, Henk G. van der Poel, Walter Noordzij, Susanne Osanto, Diederik M. Somford, Franchette W P J van den Berkmortel
Publikováno v:
European Urology Oncology, 3(2), 231-238. Elsevier BV
European Urology Oncology, 3, 2, pp. 231-238
European Urology Oncology, 3(2), 231
European urology oncology, 3(2), 231-238. Elsevier BV
European Urology Oncology, 3, 231-238
European urology oncology, 3(2), 231-238. De Tijdstroom/Elsevier
Aluwini, S S, Mehra, N, Lolkema, M P, Oprea-Lager, D E, Yakar, D, Stoevelaar, H, van der Poel, H & Dutch Oligometastatic Prostate Cancer Working Group 2020, ' Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting ', European Urology Oncology, vol. 3, no. 2, pp. 231-238 . https://doi.org/10.1016/j.euo.2019.07.010
European Urology Oncology, 3, 2, pp. 231-238
European Urology Oncology, 3(2), 231
European urology oncology, 3(2), 231-238. Elsevier BV
European Urology Oncology, 3, 231-238
European urology oncology, 3(2), 231-238. De Tijdstroom/Elsevier
Aluwini, S S, Mehra, N, Lolkema, M P, Oprea-Lager, D E, Yakar, D, Stoevelaar, H, van der Poel, H & Dutch Oligometastatic Prostate Cancer Working Group 2020, ' Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting ', European Urology Oncology, vol. 3, no. 2, pp. 231-238 . https://doi.org/10.1016/j.euo.2019.07.010
Background: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state that is imperfectly understood, and its clinical implications are unclear. Objective: To determine the consensus of a Dutch multidisciplinary expert panel on biologic
Autor:
Dagmar Grob, Bastiaan M. Privé, Constantijn H. J. Muselaers, Niven Mehra, James Nagarajah, Mark W. Konijnenberg, Steffie M. B. Peters
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-12 (2024)
Abstract Background Bone marrow toxicity in advanced prostate cancer patients who receive [177Lu]Lu-PSMA-617 is a well-known concern. In early stage patients; e.g. low volume metastatic hormone sensitive prostate cancer (mHSPC) patients, prevention o
Externí odkaz:
https://doaj.org/article/6dbce80e4d6b49a5afe0d91156498091
Autor:
Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal, Wouter W. van Willigen, Simone Hins-de Bree, Anna L. de Goede, Annemiek J. de Boer, Kevin J. H. Bos, Tjitske Duiveman-de Boer, Michel A. M. Olde Nordkamp, Tom G. M. van Oorschot, Carlijn J. Popelier, Jeanne M. Pots, Nicole M. Scharenborg, Mandy W. M. M. van de Rakt, Valeska de Ruiter, Wilmy S. van Meeteren, Michelle M. van Rossum, Sandra J. Croockewit, Bouke J. Koeneman, Jeroen H. A. Creemers, Inge M. N. Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A. van der Veldt, Dirk J. van Grünhagen, Johanna E. M. Werner, Johannes J. Bonenkamp, John B. A. G. Haanen, Marye J. Boers-Sonderen, Rutger H. T. Koornstra, Martijn F. Boomsma, Erik H. J. Aarntzen, Martin Gotthardt, James Nagarajah, Theo J. M. de Witte, Carl G. Figdor, Johannes H. W. de Wilt, Johannes Textor, Jan Willem B. de Groot, Winald R. Gerritsen, I. Jolanda M. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Autologous natural dendritic cells (nDCs) treatment can induce tumor-specific immune responses and clinical responses in cancer patients. In this phase III clinical trial (NCT02993315), 148 patients with resected stage IIIB/C melanoma were r
Externí odkaz:
https://doaj.org/article/245269452ff04a81b46a9a6846fb6516
Autor:
Hinke Siebinga, Bastiaan M. Privé, Steffie M. B. Peters, James Nagarajah, Thomas P. C. Dorlo, Alwin D. R. Huitema, Berlinda J. deWit‐van der Veen, Jeroen J. M. A. Hendrikx
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 8, Pp 1060-1071 (2023)
Abstract Studies to evaluate and optimize [177Lu]Lu‐PSMA treatment focus primarily on individual patient data. A population pharmacokinetic (PK) dosimetry model was developed to explore the potential of using imaging data as input for population PK
Externí odkaz:
https://doaj.org/article/8669aa79881c42eab0d580af6a0f9877
Autor:
Steffie M. B. Peters, Maaike C. T. Mink, Bastiaan M. Privé, Maarten de Bakker, Frank de Lange, Constantijn H. J. Muselaers, Niven Mehra, J. Alfred Witjes, Martin Gotthardt, James Nagarajah, Mark W. Konijnenberg
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Dosimetry in [177Lu]Lu-PSMA therapy is a valuable tool to assess treatment efficacy and toxicity. This study aims to develop a clinically implementable protocol to determine the absorbed dose in organs and tumor lesions after [177
Externí odkaz:
https://doaj.org/article/3cddee000ded4238802511c9b9319d05
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Willemijn A. van Gemert, Michel de Groot, Harm Westdorp, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-4 (2021)
Abstract Background The BULLSEYE trial is a multicenter, open-label, randomized controlled trial to test the hypothesis if 177Lu-PSMA is an effective treatment in oligometastatic hormone-sensitive prostate cancer (oHSPC) to prolong the progression-fr
Externí odkaz:
https://doaj.org/article/d0eae2f7bc184b94b9f6863ede0c30e8
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with external beam radiotherapy (EBRT) or targeted surgery for oligometastati
Externí odkaz:
https://doaj.org/article/05ea3477df904c7e9eba15f0eafa2c79
Autor:
Markus Krönke, Christine Eilers, Desislava Dimova, Melanie Köhler, Gabriel Buschner, Lilit Schweiger, Lemonia Konstantinidou, Marcus Makowski, James Nagarajah, Nassir Navab, Wolfgang Weber, Thomas Wendler
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0268550 (2022)
Thyroid volumetry is crucial in the diagnosis, treatment, and monitoring of thyroid diseases. However, conventional thyroid volumetry with 2D ultrasound is highly operator-dependent. This study compares 2D and tracked 3D ultrasound with an automatic
Externí odkaz:
https://doaj.org/article/179c911f08974bad8c0300d639121b15
Autor:
Walter Jentzen, Jinda Phaosricharoen, Benedikt Gomez, Philipp Hetkamp, Vanessa Stebner, Ina Binse, Sonja Kinner, Ken Herrmann, Amir Sabet, James Nagarajah
Publikováno v:
EJNMMI Physics, Vol 5, Iss 1, Pp 1-13 (2018)
Abstract Background In patients with differentiated thyroid cancer (DTC), serial 124I PET/CT imaging is, for instance, used to assess the absorbed (radiation) dose to lesions. Frequently, the lesions are located in the neck and they are close to or s
Externí odkaz:
https://doaj.org/article/706c3da427a04d27bdf21b59455ba258